Skip to main content

Table 5 Average and Incremental Cost and Effect Outcomes per Pregnant Woman per Annum

From: Perinatal HIV transmission and the cost-effectiveness of screening at 14 weeks gestation, at the onset of labour and the rapid testing of infants

 

Strategy

Cost ($)

Effect (LYG)

Incremental Cost ($)

Incremental Effect (LYG)

ICER

J

Universal screening by 14 weeks gestation and screening of the infant at birth

-737.70

0.2037

   

H

Universal screening by 14 weeks gestation or screening at the onset of labour or screening of the infant at birth

-730.55

0.2013

7.15

-0.0023

Dominated

F

Universal screening by 14 weeks gestation or screening of the infant at birth

-718.82

0.2001

18.88

-0.0036

Dominated

I

Universal screening by 14 weeks gestation and screening at the onset of labour

-646.90

0.1627

90.81

-0.0409

Dominated

E

Universal screening by 14 weeks gestation or screening at the onset of labour

-639.95

0.1636

97.76

-0.0400

Dominated

B

Universal screening by 14 weeks gestation

-600.54

0.1485

137.16

-0.0552

Dominated

G

Universal screening at the onset of labour or screening the infant at birth

-298.17

0.1443

439.54

-0.0594

Dominated

C

Universal screening at the onset of labour

-89.46

0.0389

648.24

-0.1648

Dominated

D

Universal screening of the infant at birth

-75.02

0.1409

662.69

-0.0628

Dominated

A

Sporadic screening

714.05

0.0000

1451.75

-0.2037

Dominated